Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
, (GLP-1)
Liu P, et al
Without insurance, the price varies by dose
The global obesity drug market is anticipated to grow at a compound annual growth rate (CAGR) of over 10% through 2030, with tirzepatide expected to capture a significant portion of this growth [5]
_edited.jpg)
The main differences between the two peptides are as follows: Mechanism of Action: Tirzepatide has an affinity to the receptors of another incretin hormone called Gastric Inhibitory Peptide (GIP) and also has some affinity to the GLP-1 receptors
US$ 22.11
US$ 28.70
US$ 29.49
US$ 26.27
